anonymous
Guest
anonymous
Guest
The Eliquis patient who misses a dose is taking Xarelto. The drugs have the same half life. The once a day was a marketing tool. Eliquis is preferred because it works just as well with less bleeds, especially GI bleeds. It’s about lowering the risk of adverse outcomes…wonder why the more recent Xarelto indications are twice daily dosing.
OK - Should we listen to you - cheerleader - or Duke Clinical Research Institute- who understood your drug apixiban needed BID because of pharmodynamics. Half life is only part of it. This same group also created Rocket the Xarelto study. You child.